Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
C21 Investments ( (TSE:CXXI) ) just unveiled an announcement.
C21 Investments Inc. reported a 3% increase in fourth-quarter revenue, reaching $8.1 million, driven by same-store sales growth across all dispensaries despite a 6.5% decline in Nevada state sales. For the fiscal year ending March 31, 2025, the company achieved a revenue of $30.1 million, marking a 6.5% increase over the previous year. The South Reno dispensary showed exceptional performance with over 100% same-store sales growth since its opening. The company’s disciplined approach resulted in sustained free cash flow and improved margins, demonstrating resilience in a challenging market environment.
Spark’s Take on TSE:CXXI Stock
According to Spark, TipRanks’ AI Analyst, TSE:CXXI is a Neutral.
C21 Investments faces significant challenges in profitability and cash flow, affecting its financial health and valuation. However, recent corporate events including strong third-quarter results and a strategic share repurchase provide a positive outlook, balancing some of the financial and technical weaknesses.
To see Spark’s full report on TSE:CXXI stock, click here.
More about C21 Investments
C21 Investments Inc. is a vertically integrated cannabis company operating in the cannabis industry. The company focuses on the cultivation, processing, and retailing of cannabis products, with a significant market presence in Nevada, USA.
YTD Price Performance: -27.27%
Average Trading Volume: 33,476
Technical Sentiment Signal: Sell
Current Market Cap: C$24.01M
For detailed information about CXXI stock, go to TipRanks’ Stock Analysis page.